These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26022560)
1. Introduction to the supplement. Rappuoli R Vaccine; 2015 Jun; 33 Suppl 2():B1-2. PubMed ID: 26022560 [TBL] [Abstract][Full Text] [Related]
2. Developing vaccines for an aging population. Black S; De Gregorio E; Rappuoli R Sci Transl Med; 2015 Apr; 7(281):281ps8. PubMed ID: 25834107 [TBL] [Abstract][Full Text] [Related]
3. The path forward. De Gregorio E Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572 [TBL] [Abstract][Full Text] [Related]
4. Gaps in knowledge and prospects for research of adjuvanted vaccines. Seder R; Reed SG; O'Hagan D; Malyala P; D'Oro U; Laera D; Abrignani S; Cerundolo V; Steinman L; Bertholet S Vaccine; 2015 Jun; 33 Suppl 2():B40-3. PubMed ID: 26022566 [TBL] [Abstract][Full Text] [Related]
5. Are we entering a new age for human vaccine adjuvants? O'Hagan DT; Fox CB Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042 [TBL] [Abstract][Full Text] [Related]
6. Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland. Collin N Hum Vaccin Immunother; 2013 Sep; 9(9):2015-6. PubMed ID: 23966098 [TBL] [Abstract][Full Text] [Related]
14. Innovative vaccine production technologies: the evolution and value of vaccine production technologies. Bae K; Choi J; Jang Y; Ahn S; Hur B Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962 [TBL] [Abstract][Full Text] [Related]
15. Molecular signatures of vaccine adjuvants. Olafsdottir T; Lindqvist M; Harandi AM Vaccine; 2015 Sep; 33(40):5302-7. PubMed ID: 25989447 [TBL] [Abstract][Full Text] [Related]